Detalles de la búsqueda
1.
Efficacy of TAC-302 for patients with detrusor underactivity and overactive bladder: a randomized, double-blind, placebo-controlled phase 2 study.
World J Urol
; 40(11): 2799-2805, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36205739
2.
Cardiovascular safety of vibegron, a new ß3-adrenoceptor agonist, in older patients with overactive bladder: Post-hoc analysis of a randomized, placebo-controlled, double-blind comparative phase 3 study.
Neurourol Urodyn
; 40(6): 1651-1660, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34139038
3.
Botulinum toxin injections for Japanese patients with urinary incontinence caused by neurogenic detrusor overactivity: Clinical evaluation of onabotulinumtoxinA in a randomized, placebo-controlled, double-blind trial with an open-label extension.
Int J Urol
; 28(9): 906-912, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34075630
4.
Efficacy and safety of the noradrenaline reuptake inhibitor, TAS-303, in women with stress urinary incontinence: Results of a double-blind, randomized, placebo-controlled, early phase II trial.
Int J Urol
; 28(1): 82-90, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33145841
5.
Clinical Guidelines for Female Lower Urinary Tract Symptoms (second edition).
Int J Urol
; 28(5): 474-492, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33650242
6.
Efficacy of vibegron, a novel ß3-adrenoreceptor agonist, on severe urgency urinary incontinence related to overactive bladder: post hoc analysis of a randomized, placebo-controlled, double-blind, comparative phase 3 study.
BJU Int
; 125(5): 709-717, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31991511
7.
Duration of smoking cessation is negatively associated with the magnitude of chronic prostatic inflammation and storage dysfunction in patients with benign prostatic hyperplasia.
Int J Urol
; 27(10): 874-881, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32710513
8.
OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single-dose treatment from a phase III, randomized, double-blind, placebo-controlled trial (interim analysis).
Int J Urol
; 27(3): 227-234, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31957922
9.
Preferential expression of sialyl 6'-sulfo N-acetyllactosamine-capped O-glycans on high endothelial venules in human peripheral lymph nodes.
Lab Invest
; 99(10): 1428-1441, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31148596
10.
Low and high body mass index values are associated with female nocturia.
Neurourol Urodyn
; 38(8): 2250-2254, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31338884
11.
Serum C-reactive protein level is not associated with prostatic inflammation but with overactive detrusor in patients with benign prostatic hyperplasia.
Neurourol Urodyn
; 38(6): 1728-1736, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31165507
12.
α1 -Blocker inhibits non-voiding contractions and decreases the level of intravesical prostaglandin E2 in rats with partial bladder outlet obstruction.
Int J Urol
; 26(9): 924-930, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31317581
13.
Efficacy of novel ß3 -adrenoreceptor agonist vibegron on nocturia in patients with overactive bladder: A post-hoc analysis of a randomized, double-blind, placebo-controlled phase 3 study.
Int J Urol
; 26(3): 369-375, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30557916
14.
Long-term safety and efficacy of antimuscarinic add-on therapy in patients with overactive bladder who had a suboptimal response to mirabegron monotherapy: A multicenter, randomized study in Japan (MILAI II study).
Int J Urol
; 26(3): 342-352, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30548692
15.
Prostatic stromal inflammation is associated with bladder outlet obstruction in patients with benign prostatic hyperplasia.
Prostate
; 78(10): 743-752, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29608020
16.
Efficacy and safety of fesoterodine treatment for overactive bladder symptoms in elderly women with and without hypertension.
Int J Urol
; 25(3): 251-257, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29224251
17.
Early improvement of storage or voiding symptoms by tadalafil predicts treatment outcomes in patients with lower urinary tract symptoms from benign prostatic hyperplasia.
Int J Urol
; 25(3): 240-245, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29094398
18.
Therapeutic effect of propiverine hydrochloride on mixed-type urinary incontinence in women: The Female Urgency and Stress Urinary Incontinence Study of Propiverine Hydrochloride trial.
Int J Urol
; 25(5): 486-491, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29651806
19.
Appearance of High Endothelial Venule-Like Vessels in Benign Prostatic Hyperplasia is Associated With Lower Urinary tract Symptoms.
Prostate
; 77(7): 794-802, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28181681
20.
Nocturnal Polyuria and Hypertension in Patients with Lifestyle Related Diseases and Overactive Bladder.
J Urol
; 197(2): 423-431, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27565397